Stock ALBLU BLUELINEA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bluelinea

Equities

ALBLU

FR0011041011

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris
Other stock markets
 03:00:07 2024-04-26 am EDT 		5-day change 1st Jan Change
1.06 EUR 0.00% Intraday chart for Bluelinea -1.85% -18.46%
Apr. 04 Bluelinea Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Global markets live: Warner, Givaudan, Apple, Tesla, AMC... Our Logo

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 24.96 17.66 19.19 21.07 12.2 18.11
Enterprise Value (EV) 1 24.5 17.56 20.02 23.52 15.58 17.24
P/E ratio -8.35 x -6.45 x -6.88 x -7.8 x -3.81 x -11.8 x
Yield - - - - - -
Capitalization / Revenue 3.78 x 2.52 x 2.74 x 2.91 x 1.51 x 1.58 x
EV / Revenue 3.71 x 2.5 x 2.86 x 3.25 x 1.92 x 1.51 x
EV / EBITDA -11.9 x -11.9 x -10.6 x -13.2 x -6.55 x 38.4 x
EV / FCF -23.1 x -12.5 x 99.3 x -9.53 x 16.7 x -11.1 x
FCF Yield -4.32% -8.01% 1.01% -10.5% 5.99% -8.99%
Price to Book 3.93 x 3.49 x 8.47 x 23.8 x -6.79 x 4.23 x
Nbr of stocks (in thousands) 3,467 3,839 3,839 4,148 4,148 12,237
Reference price 2 7.200 4.600 5.000 5.080 2.940 1.480
Announcement Date 4/25/18 4/30/19 4/28/20 4/13/21 11/2/22 4/4/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 6.611 7.018 7.005 7.248 8.096 11.44
EBITDA 1 -2.053 -1.474 -1.896 -1.786 -2.379 0.4485
EBIT 1 -3.308 -2.734 -3.178 -3.033 -3.224 -0.8406
Operating Margin -50.04% -38.95% -45.36% -41.85% -39.82% -7.35%
Earnings before Tax (EBT) 1 -3.561 -3.195 -3.174 -3.027 -3.663 -1.55
Net income 1 -2.991 -2.739 -2.789 -2.701 -3.303 -1.544
Net margin -45.25% -39.04% -39.81% -37.26% -40.8% -13.49%
EPS 2 -0.8628 -0.7136 -0.7265 -0.6511 -0.7717 -0.1257
Free Cash Flow 1 -1.058 -1.407 0.2016 -2.468 0.9339 -1.55
FCF margin -16.01% -20.05% 2.88% -34.05% 11.53% -13.54%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/25/18 4/30/19 4/28/20 4/13/21 11/2/22 4/4/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 0.83 2.45 3.39 -
Net Cash position 1 0.47 0.1 - - - 0.87
Leverage (Debt/EBITDA) - - -0.4378 x -1.372 x -1.424 x -
Free Cash Flow 1 -1.06 -1.41 0.2 -2.47 0.93 -1.55
ROE (net income / shareholders' equity) -38.1% -48% -76.2% -171% 683% -126%
ROA (Net income/ Total Assets) -18.7% -18.4% -25.1% -26.4% -26% -4.95%
Assets 1 15.97 14.91 11.1 10.25 12.72 31.21
Book Value Per Share 2 1.830 1.320 0.5900 0.2100 -0.4300 0.3500
Cash Flow per Share 2 0.2500 0.1300 0.0400 0.1300 0.1300 0.3700
Capex 1 1.62 1.17 0.75 0.51 0.84 1.68
Capex / Sales 24.53% 16.67% 10.66% 7.01% 10.43% 14.71%
Announcement Date 4/25/18 4/30/19 4/28/20 4/13/21 11/2/22 4/4/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BLUELINEA Stock Bluelinea
-18.46% 13.9M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ALBLU Stock
  4. Financials Bluelinea